Navigation Links
Safeway Raises Over $9 Million to Fund Prostate Cancer Research
Date:7/25/2012

PLEASANTON, Calif., July 25, 2012 /PRNewswire/ -- Safeway Inc. (NYSE: SWY) today announced that its month-long Prostate Cancer Awareness Campaign raised over $9 million to help find new treatments and an ultimate cure for prostate cancer.

"We are infinitely grateful for all of the customer and community support for a campaign that will help save the lives of countless men worldwide," said Larree Renda, Safeway Executive Vice President and Chair of the Safeway Foundation. "Prostate cancer is the number one cancer killer of men. These contributions, one dollar at a time, are sparing lives by funding critical research and the absolute best treatment at the most renowned cancer centers in North America."

This is the 12th year that Safeway, one of the largest corporate supporters of cancer research, has dedicated the entire month of June to raising funds at its stores, production facilities and corporate offices for prostate cancer research. The company works with the Prostate Cancer Foundation to identify and provide grants for promising research. The outcomes of the nearly 1,600 Safeway-funded research projects include the identification of more than 27 cancer-causing gene fusions, new biomarkers for diagnosis and treatment response assessment and the development of new drugs to deliver more effective treatments for patients with advanced stages of the disease. The death rate has dropped roughly 40 percent in the U.S. alone, meaning nearly 200,000 American men are alive today because of improved treatment.

"The partnership with Safeway, its customers and employees has been nothing short of amazing," said Jonathan Simons, MD, President and CEO of the Prostate Cancer Foundation. "Advancements made possible by these donations are paving the way for better methods to diagnose and treat patients battling the disease."

The 2012 Prostate Cancer Awareness Campaign included a special promotion through a partnership with Stand Up 2 Cancer — a program of the Entertainment Industry Foundation.  Actress Angie Harmon, star of TNT's original drama series, Rizzoli & Isles, appeared in public service ads (PSA's) supporting cancer research. The PSA's highlighted a limited-edition, reusable shopping bag, embossed with the words, "It starts with a wish; it can end with a cure." The bag was available for purchase at all Safeway locations in the U.S as well as online at safewayfoundation.org.

Along with prostate cancer research and support for those with disabilities, Safeway is one of the largest corporate supporters of breast cancer research. In addition, Safeway is an industry leader in environmental sustainability, ethical business practices and effective community outreach.  Safeway upholds an operating philosophy that is rooted in corporate social responsibility focused on four key fundamentals: People, Products, Community, and the Planet.  These fundamentals are "The Heart of Safeway," bringing together our passion for food and serving our customers with the rapidly developing needs of our communities and our planet. In 2011, the company raised and donated more than $180 million for hunger relief, education and the previously mentioned important causes.

ABOUT SAFEWAY www.Safeway.com 
Safeway Inc. is a Fortune 100 company and one of the largest food and drug retailers in North America, based on sales. The company operates 1,666 stores in the United States and western Canada and had annual sales of $43.6 billion in 2011. The company's common stock is traded on the New York Stock Exchange under the symbol SWY.

Contact: Teena Massingill, 925-467-3810, Teena.Massingill@Safeway.com


'/>"/>
SOURCE Safeway Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
2. Juventas Therapeutics Raises $22.2 Million Series B Financing
3. Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
4. Sangart Raises Additional $50M Series G Funding Following Interim Safety Analysis Of Phase 2b Study Of MP4OX In Severe Trauma Patients With Hemorrhagic Shock
5. Cerecor Raises $22 Million Series A Financing
6. Biotech Firm Spun Off from Childrens Hospital Raises $7 Million to Advance Magnetic-Based Vascular Treatment
7. Cowen Healthcare Royalty Partners Raises $1 Billion
8. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
9. Positron Accepts Economic Incentives Offer From The City Of Gary, Indiana For $30 Million Towards 70 MeV Cyclotron Project
10. Silence Therapeutics Announces Subscription and Open Offer to Raise up to £5.7 Million
11. Nektar Therapeutics Announces Private Placement of $125 Million of Senior Secured Notes Due in 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... October 10, 2017 , ... ... program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand program ... in Volunteer Experience from US2020. , US2020’s mission is to change the trajectory ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... 13 prestigious awards honoring scientists who have made outstanding contributions ... scheduled symposium during Pittcon 2018, the world’s leading conference and exposition for laboratory ...
(Date:10/9/2017)... , ... October 09, 2017 ... ... on October 5, 2017, in the medical journal, Epilepsia, Brain Sentinel’s SPEAC® ... gold standard, video EEG, in detecting generalized tonic-clonic seizures (GTCS) using surface ...
(Date:10/6/2017)... ... October 06, 2017 , ... On Tuesday, October 24th, ... INSIGhT, the first-ever adaptive clinical trial for glioblastoma (GBM). The featured speaker will ... free and open to the public, but registration is required. , WHAT: ...
Breaking Biology Technology:
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... - Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle ... around 15.1% over the next decade to reach approximately $1,580 million ... estimates and forecasts for all the given segments on global as ...
(Date:3/23/2017)... Research and Markets has announced the addition of the ... to 2025" report to their offering. ... The Global Vehicle Anti-Theft System Market ... the next decade to reach approximately $14.21 billion by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):